<DOC>
	<DOC>NCT01172145</DOC>
	<brief_summary>This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).</brief_summary>
	<brief_title>Treatment of Apathy in Alzheimer's Disease With Modafinil</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>diagnosis of mild to moderate stage Probable Alzheimer's disease on a stable dose of a cholinesterase inhibitor medication for at least 30 days clinically elevated levels of apathy as measured by the Frontal Systems Behavior Scale diagnosis of Major Depression focal brain lesion on neuroimaging history of significant substance abuse history of significant head trauma with loss if consciousness &gt;10 minutes</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>apathy</keyword>
	<keyword>Alzheimer's disease</keyword>
	<keyword>activities of daily living performance</keyword>
	<keyword>caregiver burden</keyword>
</DOC>